Predictors of mortality, strategies to reduce readmission and economic impact of acute decompensated heart failure - Results of the Vellore Heart Failure Registry

Abstract Aim Heart failure is a global problem that is increasing in prevalence. We undertook the initiative to compile the Vellore Heart Failure Registry (VHFR) to assess the clinical profile, mortality, risk factors and economic burden of heart failure by conducting a prospective, observational, hospital-based cohort study in Vellore, Tamil Nadu. Methods and Results This study was a prospective observational cohort study conducted at the Christian Medical College and Hospital, Vellore between January 2014 to December 2016. A total of 572 patients who satisfied the Boston criteria for “definite heart failure” were included. The primary outcome was all-cause mortality. The median duration of hospital stay was eight days. The in-hospital, one, three and six month mortalities were 13.25%, 27.3%, 32.53% and 38.15% respectively. The median duration of survival was 921 days. Readmission for heart failure constituted 42%, and the most common cause of decompensation was an infection (31.5%). The presence of cyanosis at admission, history of previous stroke or transient ischaemic attack, and ACC/AHA stage D at the time of discharge were independently associated with mortality at six months. The median total direct cost of admission was INR 84,881.00 ($ 1232.34) Conclusion The patients in the VHFR were different from those described in other cohorts. Admission for heart failure is a catastrophic health expenditure. Attempts should be made to ensure a reduction in readmission rates by targeting goal-directed therapy. As the most common cause of acute decompensation is lung infection, vaccinating all patients before discharge may also help in this regard.